InterOcean Capital Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

InterOcean Capital Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,000	Closed	-$15.1K	–	462
2022 Q4	$15.1K	Hold	17,000	–	–	﹤0.01%	398
2022 Q3	$27K	Hold	17,000	–	–	﹤0.01%	406
2022 Q2	$34K	Hold	17,000	–	–	﹤0.01%	418
2022 Q1	$40K	Hold	17,000	–	–	﹤0.01%	282
2021 Q4	$79K	Buy	17,000 +3,000	+21%	+$18.6K	﹤0.01%	265
2021 Q3	$107K	Buy	14,000 +3,000	+27%	+$25.4K	0.01%	244
2021 Q2	$107K	Hold	11,000	–	–	0.01%	251
2021 Q1	$91K	Sell	11,000 -1,200	-10%	-$12.7K	0.01%	239
2020 Q4	$83K	Buy	+12,200	New	+$98K	0.01%	225

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return